Abiopharma

🔍 Fontaine Danielle (Executive)

Company: ServiceNow, Inc. (NOW)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 235 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,168.00 | transaction_form_type: 4
• Sold 82 shares of Common Stock at $124.0 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,086.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 740 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,826.00 | transaction_form_type: 4
• Sold 256 shares of Common Stock at $124.0 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,570.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 235 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 2,355.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 740 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 10,357.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4

Footnotes:

• F1: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3.
• F2: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
• F3: The restricted stock units vest in 16 equal quarterly installments, with the first vesting having occurred on May 15, 2025, and subject to the reporting person's continued service to the Issuer on each vesting date.
• F4: The restricted stock units vest in 16 equal quarterly installments, with the first vesting having occurred on May 15, 2026, and subject to the Reporting Person's continued service to the Issuer on each vesting date.